World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
21767
World Ranking
17188
National Ranking
8616

Alan M. Garber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alan M. Garber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 314 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alan M. Garber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alan M. Garber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2017 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2017 - Fellow of the American Academy of Arts and Sciences
  • 1998 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Alan M. Garber is affiliated with Baylor College of Medicine in the United States. Their research spans several intersecting fields, incorporating elements of mathematics, medicine, and economics, econometrics, and finance.

Their work engages multiple subfields including modeling and simulation, epidemiology, and economics and econometrics. This multidisciplinary approach informs their analysis and research outputs.

Notable areas of study that have been covered in their research include:

  • COVID-19 epidemiological studies
  • Influenza Virus Research Studies
  • COVID-19 Pandemic Impacts

One recent paper authored by Alan M. Garber is titled "Learning From Excess Pandemic Deaths," published in 2021 in the journal JAMA. This paper has garnered citations indicating engagement from the research community.

The researcher appears predominantly in the journal JAMA as a publication venue, with documented contributions there.

Alan M. Garber has been recognized with several professional distinctions, including:

  • Fellow of the American Association for the Advancement of Science (AAAS), awarded in 2017
  • Fellow of the American Academy of Arts and Sciences, awarded in 2017
  • Member of the National Academy of Medicine (NAM), since 1998
  • Member of the Association of American Physicians

This list of awards reflects affiliations with prominent scientific communities and organizations.

Best Publications

  • Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

    Alan Garber;Robert Henry;Robert Ratner;Pedro A Garcia-Hernandez

  • Economic Foundations of Cost-Effectiveness Analysis

    Alan M. Garber;Alan M. Garber;Alan M. Garber;Charles E. Phelps;Charles E. Phelps

  • Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.

    Michael K. Gould;Anne D. Dembitzer;Ramona L. Doyle;Trevor J. Hastie

  • Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

    Philip Raskin;Elsie Allen;Priscilla Hollander;Andrew Lewin

  • American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

    Yehuda Handelsman;Jeffrey Mechanick;Lawrence Blonde;George Grunberger

  • Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.

    James V. Freeman;Ruo P. Zhu;Douglas K. Owens;Alan M. Garber

  • Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly

    Hau Liu;Dena M. Bravata;Ingram Olkin;Smita Nayak

  • One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel‐group, open‐label trial

    R. Pratley;M. Nauck;T. Bailey;E. Montanya

  • Cost-Effectiveness of Alternative Test Strategies for the Diagnosis of Coronary Artery Disease

    Alan M. Garber;Neil A. Solomon

  • Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness Analysis

    Michael K. Gould;Anne D. Dembitzer;Gillian D. Sanders;Alan M. Garber

  • Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging

    Sylvia K. Plevritis;Allison W. Kurian;Bronislava M. Sigal;Bruce L. Daniel

  • Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease: A Cost-Effectiveness Analysis

    Crystal M. Smith-Spangler;Jessie L. Juusola;Eva A. Enns;Douglas K. Owens

  • Does comparative-effectiveness research threaten personalized medicine?

    Alan M Garber;Sean R. Tunis

  • Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease

    Crystal M. Smith-Spangler;Jessie L. Juusola;Eva A. Enns;Douglas K. Owens

  • Is American Health Care Uniquely Inefficient

    Alan M. Garber;Jonathan Skinner

  • Trends in Inpatient Treatment Intensity among Medicare Beneficiaries at the End of Life

    Amber E. Barnato;Mark B. Mcclellan;Christopher R. Kagay;Alan M. Garber;Alan M. Garber

  • Liraglutide, a once‐daily human glucagon‐like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes

    A. Garber;R. R. Henry;R. R. Henry;R. Ratner;P. Hale

  • AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE 2014 ADVANCED FRAMEWORK FOR A NEW DIAGNOSIS OF OBESITY AS A CHRONIC DISEASE

    W. Garvey;Alan Garber;Jeffrey Mechanick;George Bray

  • Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis

    Michael K. Gould;Anne D. Dembitzer;Ramona L. Doyle;Trevor J. Hastie

  • Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: Lifestyle and Medical Management of Risk Factors

    Scott M. Grundy;Alan Garber;Ronald Goldberg;Stephen Havas

Frequent Co-Authors

Joseph P. Newhouse
Joseph P. Newhouse Harvard University
Jay Bhattacharya
Jay Bhattacharya Stanford University
Mark A. Hlatky
Mark A. Hlatky Stanford University
Mark McClellan
Mark McClellan Duke University
Victor R. Fuchs
Victor R. Fuchs Stanford University
David M. Cutler
David M. Cutler Harvard University
Dana P. Goldman
Dana P. Goldman University of Southern California
Paul A. Heidenreich
Paul A. Heidenreich Stanford University
Charles E. Phelps
Charles E. Phelps University of Rochester
Rong Xu
Rong Xu Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA can open the door to many related degrees and career options, especially for those interested in other impactful roles in healthcare. For those considering leadership, a mha degree cost is an important factor to evaluate, as it can influence your return on investment and career trajectory.

Advanced practice nurses seeking to maximize their clinical expertise often look into the cheapest dnp program to pursue their Doctor of Nursing Practice, balancing quality education with affordability. Meanwhile, prospective pharmacists should research the cheapest online pharmacy school to find credible, cost-effective pathways for earning their PharmD.

Finally, with the growing demand for data-driven healthcare, a him bachelor's degree online offers a flexible way to enter the expanding field of health information management. Comparing programs and costs across these options is crucial for making informed decisions about your healthcare career journey.

Best Scientists Citing Alan M. Garber

Trending Scientists

Recently Published Articles